RSL1D1
Ribosomal L1 domain-containing protein 1
Also known as: CSIG, DKFZP564M182, L12, PBK1, RL1D1_HUMAN, UTP30
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O76021
- Gene
- RSL1D1
- Ensembl
- ENSG00000171490
- Chromosome
- 16
- Canonical length
- 490 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Nucleoli rim,Mitotic chromosome,Vesicles,Primary cilium
OverviewNCBI Gene
Enables mRNA 3'-UTR binding activity and mRNA 5'-UTR binding activity. Involved in regulation of apoptotic process and regulation of cellular senescence. Acts upstream of or within regulation of protein localization. Located in several cellular components, including cilium; cytosol; and nucleolus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
490 residues, UniProt reviewed canonical sequence.
>O76021|RSL1D1
1 MEDSASASLS SAAATGTSTS TPAAPTARKQ LDKEQVRKAV DALLTHCKSR KNNYGLLLNE
61 NESLFLMVVL WKIPSKELRV RLTLPHSIRS DSEDICLFTK DEPNSTPEKT EQFYRKLLNK
121 HGIKTVSQII SLQTLKKEYK SYEAKLRLLS SFDFFLTDAR IRRLLPSLIG RHFYQRKKVP
181 VSVNLLSKNL SREINDCIGG TVLNISKSGS CSAIRIGHVG MQIEHIIENI VAVTKGLSEK
241 LPEKWESVKL LFVKTEKSAA LPIFSSFVSN WDEATKRSLL NKKKKEARRK RRERNFEKQK
301 ERKKKRQQAR KTASVLSKDD VAPESGDTTV KKPESKKEQT PEHGKKKRGR GKAQVKATNE
361 SEDEIPQLVP IGKKTPANEK VEIQKHATGK KSPAKSPNPS TPRGKKRKAL PASETPKAAE
421 SETPGKSPEK KPKIKEEAVK EKSPSLGKKD ARQTPKKPEA KFFTTPSKSV RKASHTPKKW
481 PKKPKVPQSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RSL1D1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 93 nTPM
Expression across tissuesHPA
Tissue
- ovary: 93 nTPM
- skeletal muscle: 80 nTPM
- breast: 74 nTPM
- tonsil: 61 nTPM
- tongue: 48 nTPM
- lymph node: 45 nTPM
Single-cell type
- esophageal basal cells: 362 nCPM
- decidual stromal cells: 360 nCPM
- migrating cytotrophoblasts: 348 nCPM
- oocytes: 345 nCPM
- extravillous trophoblasts: 331 nCPM
- ovarian stromal cells: 321 nCPM
Immune cell
- total PBMC: 252 nTPM
- naive CD4 T-cell: 186 nTPM
- naive CD8 T-cell: 137 nTPM
- memory B-cell: 133 nTPM
- myeloid DC: 131 nTPM
- memory CD4 T-cell: 130 nTPM
Brain region
- white matter: 32 nTPM
- cerebral cortex: 29 nTPM
- spinal cord: 28 nTPM
- cerebellum: 28 nTPM
- hypothalamus: 28 nTPM
- choroid plexus: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.61
- DepMap mean gene effect
- -1.39
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- osteoblast differentiation
- regulation of apoptotic process
- regulation of cellular senescence
- regulation of protein localization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RSL1D1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RSL1D1 as an antibody target. Whether an autoantibody or antibody against RSL1D1 could matter depends on whether native RSL1D1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RSL1D1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RSL1D1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...